Document:

EX-10.15

 Exhibit 10.15 

AMENDMENT TO THE LICENSE AGREEMENT 

between 
 THE UNIVERSITY
OF SOUTHERN CALIFORNIA 
 and 

ALFRED E. MANN INSTITUTE FOR BIOMEDICAL ENGINEERING AT THE UNIVERSITY OF SOUTHERN CALIFORNIA 

for 
 NanoPulse
Technology 

  
  

1 

 AMENDMENT TO THE LICENSE AGREEMENT 

This Amendment to the License Agreement (the “Amendment”) is effective this 8th day of
September, 2014 (the “Effective Date”) between THE UNIVERSITY OF SOUTHERN CALIFORNIA, a California nonprofit corporation (“USC”); ALFRED E. MANN INSTITUTE FOR BIOMEDICAL ENGINEERING AT THE UNIVERSITY OF SOUTHERN CALIFORNIA, a
Delaware corporation (“AMI-USC”); and ElectroBlate, a Nevada Corporation (“ELECTROBLATE”). 
  

	1	BACKGROUND 

  

	1.1	USC and AMI-USC are parties to a license agreement effective February 11, 2008 (the “Agreement”). 

  

	1.2	AMI-USC sublicensed its rights to ThelioPulse, Inc., a Delaware Corporation (“TPI”), effective February 27, 2012 (the “Sublicense”). 

 

	1.3	ELECTROBLATE desires to obtain all of USC’s rights licensed pursuant to the Agreement and all of AMI-USC’s rights in nanopulse-related patents and know-how, that are not subject to the Agreement and that are
described in Exhibit B to this Amendment, directly from USC and AMI-USC, respectively, and USC and AMI-USC desire to grant such rights to ELECTROBLATE, on the terms and subject to the conditions set forth below. 

 

	1.4	AMI-USC and TPI have agreed to terminate their Sublicense simultaneously with the execution of this Agreement. 

  

	1.5	USC acknowledges and accepts that AMI-USC has fulfilled all of the milestones of mandatory performance milestones of Paragraph 25c of the Agreement. 

 

	1.6	ELECTROBLATE and TPI desire that TPI merge with and into ELECTROBLATE pursuant to Internal Revenue Code § 368(a)(1)(A) with ELECTROBLATE as the surviving corporation, pursuant to a merger agreement to be executed
by TPI and ELECTROBLATE (the “Agreement and Plan of Merger”). 

 Therefore, in view of the foregoing, USC, AMI-USC, and ELECTROBLATE
hereby agree as follows: 
  

	2	DEFINITIONS 

  

	2.1	All definitions and paragraph numbers referred to in this Amendment and not otherwise defined herein shall have the same meaning as in the Agreement. 

 

	3	AMENDMENTS 

  

	3.1	AMI-USC, USC, and ELECTROBLATE agree that as of the Effective Date, ELECTROBLATE shall assume all of AMI-USC’s rights and obligations under the Agreement, as amended, with the exception of AMI’s right to
receive and distribute equity according to Paragraph 5 of the Agreement as amended herein. 

  
 [*** Confidential] indicates material
omitted and subject to a confidential information request, which has been filed separately with the SEC. 
  

2 

	3.2	The Background of the Agreement is deleted in its entirety and replaced with the following: 

This “Patent License Agreement for Nanopulse Technology” (hereinafter, the “Agreement”) is between the UNIVERSITY OF
SOUTHERN CALIFORNIA, (hereinafter “USC”) a California nonprofit corporation with its principal place of business at University Park, Los Angeles, California 90089, and ElectroBlate, a corporation existing under the laws of the State of
Nevada, (hereinafter “ELECTROBLATE”). 
 WHEREAS, prior to the “Effective Date” set forth below, USC pursued research
conducted by USC persons and which research was wholly funded by USC and the United States Government; and from which research arose the “PATENTS” set forth below; and 

WHEREAS, ELECTROBLATE desires to obtain, and USC is willing to grant to ELECTROBLATE, a [*** Confidential] license in the “Field of
Use” to certain rights in the PATENTS. 
 NOW, THEREFORE, in consideration of the covenants herein contained, the
parties agree as follows: 
  

	3.3	Paragraph 5 of the Agreement is deleted in its entirety and replaced with the following: 

a. ELECTROBLATE EQUITY. Within [*** Confidential] of the Effective Date of this Amendment, ELECTROBLATE
shall issue, in accordance with the “Agreement and Plan of Merger,” shares of its common stock to AMI-USC, or AMI-USC’s designee(s), as designated by AMI-USC in its sole discretion. AMI-USC shall divide, or shall have directed
ELECTROBLATE to divide, such Common Stock among the following parties in the amounts specified below: 
  

	 	(i)	[*** Confidential] percent ([*** Confidential]%) to [*** Confidential]; 

  

	 	(ii)	[*** Confidential] percent ([*** Confidential]%) to [*** Confidential]; 

  

	 	(iii)	[*** Confidential] percent ([*** Confidential]%) to [*** Confidential]; and 

  

	 	(iv)	[*** Confidential] percent ([*** Confidential]%) to [*** Confidential]. 

  

	3.4	Paragraph 15 of the Agreement is deleted in its entirety and replaced with the following: 

 a.
This Agreement may be terminated at any time by mutual written consent of AMI-USC, USC, and ELECTROBLATE. 
 b. Notwithstanding the
provisions of paragraph 15(a), USC may terminate this Agreement effective immediately upon the postmarked date of delivery of written notice to ELECTROBLATE if either: a) ELECTROBLATE fails to receive at least $3 million in private cash funding by
January 1, 2016; or b) ELECTROBLATE makes an assignment for the benefit of creditors, or has a bankruptcy petition filed by or against it which is not vacated within [*** Confidential], or a receiver or trustee in bankruptcy or similar
officer is appointed to take charge of all or part of ELECTROBLATE’s property. 

  
 [*** Confidential] indicates material
omitted and subject to a confidential information request, which has been filed separately with the SEC. 
  

3 

 c. Upon any termination of this Agreement all rights granted to or provided by each party to the
other shall automatically and irrevocably revert to the granting party. Any sublicenses granted by ELECTROBLATE to SUBLICENSEES shall immediately terminate upon any termination of this Agreement. 

d. Surviving any valid termination of this Agreement are: 

(i) Any financial or fiduciary obligations that have matured prior to any termination of this Agreement, such as without limitation the
allocation of any ELECTROBLATE common stock specified in paragraph 5; 
 (ii) ELECTROBLATE’s obligation of Paragraph 8 to keep and allow
a final audit; 
 (iii) Any cause of action or claim of ELECTROBLATE, AMI-USC, or USC, accrued or to accrue, because of any breach or default
by the other party; and 
 (iv) The provisions of Paragraphs 21, 22, 23, and 29. 

e. Upon termination of this Agreement, ELECTROBLATE agrees to immediately discontinue (and shall cause each SUBLICENSEE to discontinue) the
manufacture and sale of the PRODUCTS and the use of the PATENTS. Within [*** Confidential] after such termination, ELECTROBLATE shall provide USC with a written inventory of all PRODUCTS currently in its stock (and in the stock of any
SUBLICENSEE) as of the date of termination (the “INVENTORY”). USC shall have the option to grant to AMI and/or each SUBLICENSEE the privilege of disposing of such INVENTORY at normal prices within [*** Confidential] after said
termination. The disposition of all such INVENTORY, however, shall be subject to all of the terms and conditions of this Agreement. After the [*** Confidential] sell-off period, ELECTROBLATE shall destroy or return to USC all remaining unsold
PRODUCTS in its possession, all equipment used by ELECTROBLATE and any SUBLICENSEE in the manufacture of the PRODUCTS and all packaging and marketing materials in its possession pertaining to the PRODUCTS, and shall certify their destruction or
return to USC specifying the number of each destroyed or returned. All payment obligations hereunder, including without limitation any portion common stock grant to ELECTROBLATE corresponding to the then-current Calendar Year that remains unpaid as
of the effective date of termination, shall be accelerated and shall become immediately due and payable. 
  

	3.5	Section 16 of the Agreement is amended to add the following receiving party of notices: 

ELECTROBLATE: 
 ElectroBlate,
Inc. 
 401 Wilshire Boulevard 

Suite 1020 
 Santa Monica, CA
90401 

  
 [*** Confidential] indicates material
omitted and subject to a confidential information request, which has been filed separately with the SEC. 
 4 

	3.6	Exhibit A of the Agreement is deleted in its entirety and replaced with the new attached Exhibit A. 

  

	4	RELATED AGREEMENTS 

  

	4.1	It is a condition to the execution and delivery of this Amendment that TPI and AMI-USC simultaneously execute a termination and release of their Sublicense, that AMI-USC assigns to ELECTROBLATE its nanopulse-related
patents and know-how that are not subject to the Agreement and that are described in Exhibit B to this Amendment, and that ThelioPulse and Electroblate execute the “Agreement and Plan of Merger”. 

The remaining provisions of the Agreement remain in full force and effect. 

This Amendment may be executed in one or more counterparts. Delivery of an executed counterpart of this Amendment by facsimile or a PDF data file or other
scanned executed counterpart by email shall be equally as effective as delivery of a manually executed counterpart of this Amendment. Each duplicate and counterpart of this Amendment shall be equally admissible in evidence, and each shall fully bind
each party who has executed it. The parties agree that a copy of the original signature (including an electronic copy) may be used for any and all purposes in respect of this Amendment for which the original signature may have been used. The parties
agree that neither party will have any rights to challenge the use or authenticity of a counterpart of this Amendment based solely on that its signature, or the signature of the other party, on such counterpart is not an original signature. 

 

			
	AGREED AND ACCEPTED:	  	
		
	AMI-USC	  	USC
		
	By: /S/ Jonathan G. Lasch	  	By: /S/ Jennifer Dyer
	                    (Signature)	  	                    (Signature)
		
	Name: Jonathan G. Lasch	  	Name: Jennifer Dyer
		
	Title: Executive Director	  	Title: Executive Director
		
	Date: Sept. 18, 2014	  	Date: September 18, 2014

  

			
	ELECTROBLATE
		
	By:	 	/S/ Christopher A. Marlett
		 	(Signature)
		
	Name:	 	Christopher A. Marlett
		
	Title:	 	President
		
	Date:	 	September 30, 2014

  
 [*** Confidential] indicates material
omitted and subject to a confidential information request, which has been filed separately with the SEC. 
  

5EX-10.1

 Exhibit 10.1 

Execution Version 

AMENDMENT TO SETTLEMENT AGREEMENT 

This Amendment to the Settlement Agreement (this “Amendment”) dated March 4, 2016, is entered into by and among the
persons and entities listed on Schedule A (collectively, the “Stadium Capital Group”, and each, individually, a “member” of the Stadium Capital Group), Big 5 Sporting Goods Corporation (the
“Company”), Dominic P. DeMarco, in his individual capacity and as a member of the Stadium Capital Group, and Nicholas Donatiello, Jr., in his individual capacity. 

WHEREAS, on April 30, 2015, the Stadium Capital Group, Mr. Donatiello and the Company entered into the Settlement Agreement (the
“Agreement”); 
 WHEREAS, the parties to the Agreement now wish to extend and amend certain provisions of the
Agreement; 
 WHEREAS, the parties to the Agreement provided that the Agreement may be amended only by an agreement in a writing executed by
the parties to the Agreement; and 
 WHEREAS, the parties to the Agreement intend to amend only those specific provisions addressed in this
Amendment, and otherwise not to change or affect any of the other provisions of the Agreement. 
 NOW, THEREFORE, in consideration of and
reliance upon the mutual covenants and agreements contained herein and in the Agreement, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree to amend the Agreement as
follows: 
 1. Capitalized Terms. Capitalized terms used but not defined herein have the meaning ascribed to them
in the Agreement. 
 2. Board and Board Committees.  

(a) Board Size and Replacement Directors. During the Standstill Period (as defined below), the Board and all committees and
subcommittees of the Board shall not (a) seek to increase the size of the Board to more than eight (8) members or (b) change the classes on which the board members serve without the prior written consent of the Stadium Capital Group;
provided, however, that the Board may recruit potential directors or director nominees, announce retirements or departures of directors and replace retired or departed directors (a “Replacement Director”)
without the prior written consent of the Stadium Capital Group so long as (i) the Board is not increased to more than eight (8) members during the Standstill Period and (ii) if the Company continues to have a classified board of directors, the
Replacement Director will be appointed to the same class of the Board as the departing director whom he or she replaces. The Company also agrees that any Replacement Director appointed pursuant to this Section 2(a) shall (A) meet all
director independence and other standards of Nasdaq and the Securities and Exchange Commission (the “SEC”) and applicable provisions of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and the rules and regulations promulgated thereunder and (B) be qualified to serve as a director under the Delaware General Corporation Law (the “DGCL”) (clauses (A) and (B), the
“Independence Conditions”). Each Replacement Director will promptly advise the Nominating Committee if he or she ceases to satisfy any of the Independence Conditions. 

(b) Committees of the Board. 

(i) Compensation and Nominating Committees. The Board shall take all actions necessary to reappoint Mr. DeMarco as
a member of the Compensation Committee and Mr. Donatiello as a member of the Nominating Committee. 
 (ii) Value Creation
Committee. The charter for the Value Creation Committee shall be amended as set forth on Exhibit A hereto. Additionally, with the exception of Steven G. Miller, the Value Creation Committee shall be comprised solely of members
of the Board who qualify as “independent” pursuant to the standards of Nasdaq. The Value Creation Committee shall be co-chaired by Mr. DeMarco and Mr. Van B. Honeycutt; the other members of the Value Creation Committee shall be Mr. Galvin
(or, in the event Mr. Galvin is unable to serve on the Value Creation Committee at any time during the Standstill Period, an additional director as mutually agreed upon by the Board and the Stadium Capital Group; provided that, for the
avoidance of doubt, the Value Creation Committee will continue with three members until the additional director is appointed) and Mr. Miller. During the Standstill Period, the Value Creation Committee (i) shall have no more than four (4)
members, one of whom shall be designated by the Stadium Capital Group and (ii) shall have two (2) co-chairs, one of whom shall be designated by the Stadium Capital Group. 
  

  
 1 

 Execution Version 

 

 (iii) Other Committees. Subject to the standards of
Nasdaq, the Board and all committees and subcommittees of the Board shall take all actions necessary and appropriate to ensure that each committee and subcommittee of the Board formed during the Standstill Period (other than a committee or
subcommittee formed to evaluate and/or take action with respect to (a) the ownership of shares by the Stadium Capital Group, (b) the exercise of the Company’s rights or enforcement of any of the Stadium Capital Group’s obligations under
the Agreement (including this Amendment) or (c) any transactions proposed by the Stadium Capital Group or any of its affiliates) includes at least one Stadium Capital Designee or one Stadium Capital Replacement Director. Except as specifically
provided above, the Company agrees that, during the Standstill Period, neither the Company nor the Board shall create any committee that has the right to exercise all of the authority of the Board in the management of the business affairs of the
Company unless Mr. DeMarco (or, if Mr. DeMarco is no longer serving on the Board, Mr. Donatiello or a Stadium Capital Replacement Director) is appointed to such committee. 

3. Standstill. 

(a) The Stadium Capital Group agrees that, until the earlier of (i) ten (10) days prior to the deadline for submission of stockholder nominees
for the Company’s 2017 annual meeting of stockholders or (ii) the date that is 100 days prior to the first anniversary of the 2016 Annual Meeting (the “Standstill Period”), neither it nor its Affiliates or Associates (as
such terms are defined in Rule 12b-2 promulgated by the SEC under the Exchange Act) (collectively and individually referred to as the “Stadium Capital Affiliates,” provided that no portfolio company of the Stadium
Capital Group shall be deemed a “Stadium Capital Affiliate”) shall, directly or indirectly, alone or in concert with others: 

(i) make, engage in, or in any way participate in, directly or indirectly, any “solicitation” of proxies (as such
terms are used in the proxy rules of the SEC but without regard to the exclusion set forth in Rule 14a-1(l)(2)(iv) of the Exchange Act) except as otherwise provided for in the Agreement (including this Amendment); 

(ii) form, join, or in any way participate in any Group (as such term is defined in Section 13(d)(3) of the Exchange Act) with
any persons who are not Stadium Capital Affiliates with respect to any securities of the Company or otherwise in any manner agree, attempt, seek or propose to deposit any securities of the Company in any voting trust or similar arrangement, or
subject any securities of the Company to any arrangement or agreement with respect to the voting thereof, except as expressly set forth in the Agreement (including this Amendment); 

(iii) acquire, offer or propose to acquire, or agree to acquire, directly or indirectly, whether by purchase, tender or
exchange offer, any securities of the Company that would result in the Stadium Capital Group (together with the Stadium Capital Affiliates) owning, controlling or otherwise having any beneficial or other ownership interest in more than 14% in the
aggregate of the shares of Common Stock outstanding at such time; provided, that, nothing herein will require Common Stock to be sold to the extent the Stadium Capital Group and the Stadium Capital Affiliates, collectively, exceed the
ownership limit under this paragraph as the result of a share repurchase or similar Company actions that reduces the number of outstanding shares of Common Stock; 

(iv) sell, offer or agree to sell directly or indirectly, through swap or hedging transactions or otherwise, the securities of
the Company or any rights decoupled from the underlying securities of the Company held by the Stadium Capital Group or any Stadium Capital Affiliate to any person or entity that is not (A) a party to the Agreement, (B) a member of the Board, (C) an
officer of the Company or (D) a Stadium Capital Affiliate (any person or entity not set forth in clauses (A)-(D) shall be referred to as a “Third Party”), that would knowingly result in such Third Party, together with
its affiliates and associates, owning, controlling or otherwise having any beneficial or other ownership interest in the aggregate of more than 10% of the shares of Common Stock outstanding at such time, except in a transaction approved by the Board
or in an arms-length transaction to a nationally recognized brokerage firm where the Stadium Capital Group is not otherwise aware of the identity of the buyer of the shares; 

  
 2 

 Execution Version 

 

 (v) (A) make any proposal for consideration by stockholders at any annual or
special meeting of stockholders of the Company, (B) make any offer or proposal (with or without conditions) with respect to any tender or exchange offer, merger, acquisition, recapitalization, restructuring, disposition or other business
combination involving the Company or its material assets (each, an “Extraordinary Transaction”), or (C) call or seek to call a special meeting of stockholders; 

(vi) unless otherwise approved by the Board, take any public action in support of, take any action that would cause or require
the Company to make public disclosure of, or make any proposal or request that constitutes: (A) advising, controlling, changing or influencing the Board or management of the Company, including any plans or proposals to change the number or term
of directors or to fill any vacancies on the Board (other than as provided in the Agreement (including this Amendment)); (B) any material change in the capitalization, stock repurchase programs and practices or dividend policy of the Company; (C)
any other material change in the Company’s management, business or corporate structure (other than as provided in the Agreement (including this Amendment)); (D) seeking to have the Company waive or make amendments to the Charter or Bylaws
(other than as provided in the Agreement (including this Amendment)), or other actions that may impede or facilitate the acquisition of control of the Company by any person; (E) causing a class of securities of the Company to be delisted from, or to
cease to be authorized to be quoted on, any securities exchange; or (F) causing a class of securities of the Company to become eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; 

(vii) seek, or encourage any person, to submit nominations in furtherance of a “contested solicitation” for the
election or removal of directors with respect to the Company or seek, encourage or take any other action with respect to the election or removal of any directors; 

(viii) seek, alone or in concert with others, representation on the Board, except as specifically provided for in the Agreement
(including this Amendment); 
 (ix) seek to advise, encourage, support or influence any person with respect to the voting or
disposition of securities of the Company at any annual or special meeting of stockholders except as specifically provided for in the Agreement (including this Amendment); 

(x) make any public disclosure, announcement or statement regarding any intent, purpose, plan or proposal with respect to the
Board, the Company, its management, policies or affairs, any of its securities or assets or the Agreement (including this Amendment) that is inconsistent with the provisions of the Agreement (including this Amendment); or 

(xi) enter into any discussions, negotiations, agreements, or understandings with any Third Party with respect to any of the
foregoing, or advise, assist, knowingly encourage or seek to persuade any Third Party to take any action or make any statement with respect to any of the foregoing, or otherwise take or cause any action or make any statement inconsistent with any of
the foregoing. 
 (b) Each member of the Stadium Capital Group shall cause all shares of Common Stock beneficially owned, directly or
indirectly, by it, or by any Stadium Capital Affiliate, as applicable, to be present for quorum purposes and to be voted, at the 2016 Annual Meeting and at any adjournments or postponements thereof, in favor of (i) the re-election of any individual
who is a director of the Company as of the date of this Amendment, subject, in each case, to nomination of such director by the Board, (ii) the 2016 Declassified Board Proposal, (iii) the 2016 Supermajority Voting Proposal, (iv) the
“say-on-pay” vote regarding the compensation paid to the Company’s named executive officers and (v) the ratification of the appointment of Deloitte & Touche LLP to serve as the Company’s independent auditors for fiscal year
2016. Except as specifically set forth above, the Stadium Capital Group may vote their shares of Common Stock in their discretion. 

  
 3 

 Execution Version 

 

 For purposes of the Agreement (including this Amendment), the terms “person” or
“persons” shall mean any individual, corporation (including not-for-profit), general or limited partnership, limited liability or unlimited liability company, joint venture, estate, trust, association, organization or other
entity of any kind or nature. 
 (c) Nothing in this Section 3 shall limit, in any way, any action that may be taken by any Stadium
Capital Designee (or any Stadium Replacement Director), acting solely in their capacity as a director of the Company, as necessary and appropriate to comply with their fiduciary duties to the Company and its stockholders. 

4. Representations of the Company. The Company represents and warrants as follows: (a) the Company has the
power and authority to execute, deliver and carry out the terms and provisions of this Amendment and to consummate the transactions contemplated hereby; (b) this Amendment has been duly and validly authorized, executed and delivered by the Company,
constitutes a valid and binding obligation and agreement of the Company and is enforceable against the Company in accordance with its terms; and (c) the execution, delivery and performance of this Amendment by the Company does not and will not
violate or conflict with (i) any law, rule, regulation, order, judgment or decree applicable to the Company, or (ii) result in any breach or violation of or constitute a default (or an event which with notice or lapse of time or both could
constitute such a breach, violation or default) under or pursuant to, or result in the loss of a material benefit under, or give any right of termination, amendment, acceleration or cancellation of, any organizational document, agreement, contract,
commitment, understanding or arrangement to which the Company is a party or by which it is bound. 
 5. Representations of the Stadium
Capital Group. The Stadium Capital Group, jointly and severally, represents and warrants as follows: (a) the Stadium Capital Group has the power and authority to execute, deliver and carry out the terms and provisions of this
Amendment and to consummate the transactions contemplated hereby; (b) this Amendment has been duly and validly authorized, executed and delivered by the Stadium Capital Group, constitutes a valid and binding obligation and agreement of the Stadium
Capital Group and is enforceable against the Stadium Capital Group in accordance with its terms; and (c) the Stadium Capital Group, together with the Stadium Capital Affiliates, beneficially owns, directly or indirectly, an aggregate of 2,890,811
shares of Common Stock and such shares of Common Stock constitute all of the Common Stock beneficially owned by the Stadium Capital Group, the Stadium Capital Affiliates or in which the Stadium Capital Group, the Stadium Capital Affiliates have any
interest or right to acquire, whether through derivative securities, voting agreements or otherwise. 
 6. Entire Agreement;
Amendment. Other than as expressly set forth in this Amendment, the terms of the Agreement shall remain in full force and effect. 

7. SEC Filings. 

(a) The Company shall file promptly with the SEC a Form 8-K reporting entry into this Amendment (the “Form 8-K”) and
appending this Amendment as an exhibit thereto. 
 (b) The Stadium Capital Group shall promptly, but in no case prior to the date of filing
of the Form 8-K by the Company, file an amendment to the Stadium Capital Schedule 13D, reporting the entry into this Amendment and appending this Amendment as an exhibit thereto. 

8. Expenses. All attorneys’ fees, costs and expenses incurred in connection with this Amendment and all matters related
hereto will be paid by the party incurring such fees, costs or expenses. 
 9. Counterparts. This Amendment
may be executed in two or more counterparts either manually or by electronic or digital signature (including by facsimile or electronic mail transmission), each of which shall be deemed to be an original and all of which together shall constitute a
single binding agreement on the parties hereto, notwithstanding that not all parties are signatories to the same counterpart. 

  
 4 

 IN WITNESS WHEREOF, each of the parties hereto has executed this AMENDMENT TO SETTLEMENT
AGREEMENT or caused the same to be executed by its duly authorized representative as of the date first above written. 
  

					
	Big 5 Sporting Goods Corporation
			
		 	By:	 	 /s/ Steven G. Miller

		 	Name:	 	Steven G. Miller
		 	Title:	 	Chairman, President and CEO

  
  
  

 
  
  

 

  
 [Signature Page —
Amendment to Settlement Agreement] 

 IN WITNESS WHEREOF, each of the parties hereto has executed this AMENDMENT TO SETTLEMENT
AGREEMENT or caused the same to be executed by its duly authorized representative as of the date first above written. 
  

			
	Stadium Capital Management, LLC
		
	By:	 	 /s/ Alexander Seaver

	Name:	 	Alexander Seaver
	Title:	 	Manager
	
	Stadium Capital Management GP, L.P.
		
	By:	 	 /s/ Alexander Seaver

	Name:	 	Alexander Seaver
	Title:	 	Manager
	
	Stadium Capital Partners, L.P.
		
	By:	 	 /s/ Alexander Seaver

	Name:	 	Alexander Seaver
	Title:	 	Manager
	
	Stadium Capital Qualified Partners, L.P.
		
	By:	 	 /s/ Alexander Seaver

	Name:	 	Alexander Seaver
	Title:	 	Manager
	
	 /s/ Dominic P. DeMarco

	Dominic P. DeMarco
	
	 /s/ Nicholas Donatiello, Jr.

	 Nicholas Donatiello, Jr.
  

 

  

  
 [Signature Page —
Amendment to Settlement Agreement] 

 Schedule A 

Members of Stadium Capital Group 
 Stadium
Capital Management, LLC 
 Stadium Capital Management GP, L.P. 

Stadium Capital Partners, L.P. 
 Stadium Capital Qualified
Partners, L.P. 
 Dominic P. DeMarco 

 Exhibit A 

Revised Value Creation Committee Charter 

(Attached) 

 VALUE CREATION COMMITTEE CHARTER 

Big 5 Sporting Goods Corporation 

Value Creation Committee 

Purpose 
 The Value Creation Committee is
appointed by the Board of Directors (the “Board”) of Big 5 Sporting Goods Corporation (the “Company”) to, among other things, review the Company’s business, operations, capital allocations and strategy, explore profit
enhancement opportunities for the Company’s business, and identify possible areas of value creation for the Company’s business and its stockholders, and to make recommendations to the Board on these issues. Additionally, the Committee
shall continue to have primary responsibility for overseeing any independent financial advisors retained by the Committee in connection with the Committee’s purpose. 

Membership and Meetings 
 The Committee
shall consist of a maximum of four (4) directors. The Committee shall be co-chaired by Mr. Dominic P. DeMarco and Mr. Van B. Honeycutt; the other members of the Committee shall be Mr. Robert C. Galvin and Mr. Steven G. Miller. Subject to the terms
of any agreement to which the Company may be party, the members of the Committee shall be appointed and may be removed solely for cause as defined by Delaware law, and shall serve for such term as the Board determines or until their successors are
elected or appointed. 
 The Committee shall (i) meet as often as its members shall determine to be necessary, or meetings may be called by either
Co-Chairman or any two (2) members of the Committee or the Chairman of the Board and (ii) hold meetings on at least two (2) business days’ prior written notice or such shorter period as to which the members of the Committee agree. The Committee
shall keep minutes and other relevant documentation of all meetings held. The Co-Chairs of the Committee shall be responsible for scheduling all meetings of the Committee, determining the agenda for each meeting (following consultation with other
members of the Committee), ensuring that the agenda for each meeting is circulated to each Committee member in advance of the meeting, presiding over meetings of the Committee and coordinating reporting to the Board. A vote of a majority of all
members of the Committee will constitute an act of the Committee. 
 The Committee shall have reasonable access to members of management, and management
shall furnish to the Committee (as well as its advisors) such financial information, projections and other information, support and cooperation as the Committee reasonably requests to assist it in performing its duties. In addition, the Committee
may obtain reasonable assistance from officers of the Company, and shall have the authority to retain and engage independent financial, legal and/or other advisors or consultants as reasonably necessary at the expense of the Company in furtherance
of the purposes and authority of the Committee as set forth above and below.

 The Committee shall make regular reports to the Board, and all recommendations of the Committee shall be reported
to the Board at the next regular meeting of the Board or otherwise as appropriate. 
 The Committee shall remain in effect until (A) the earlier of (i) ten
(10) days prior to the deadline for submission of stockholder nominees for the Company’s 2017 annual meeting of stockholders or (ii) the date that is one hundred (100) days prior to the first anniversary of the Company’s 2016 annual
meeting of stockholders or (B), if determined by the Board, thereafter. 
 Purpose and Authority 

The Committee shall have the authority to do the following: 
  

	 	1.	review the Company’s business, strategy, performance and market conditions; 

  

	 	2.	explore profit enhancement opportunities for the Company’s business; 

  

	 	3.	develop an operating improvement plan for the Company’s business; 

  

	 	4.	identify ways to maximize the value of the business for the Company and its stockholders; 

  

	 	5.	retain independent financial, legal and/or other advisors and consultants at the expense of the Company to advise and assist it in considering these issues; and 

 

	 	6.	make recommendations to the Board for the Board’s consideration in deciding whether or not to approve and implement any (or all) of the above-referenced matters. 

Confidentiality 
 Subject to and consistent
with each Committee Member’s fiduciary and/or contractual duties to the Company and its stockholders, each member of the Committee shall preserve the confidentiality of the Committee’s communications, deliberations and recommendations and
of information and material supplied to the Committee in the course of its duties (collectively, the “Confidential Information”). Consistent with the above-provision, no member of the Committee shall use any Confidential Information for a
purpose other than as contemplated by this Charter or disclose any Confidential Information other than to (i) the Board, (ii) the Committee’s outside advisors or (iii) any person to whom disclosure of Confidential Information is required by
law. 
 *****

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00255-of-00352.parquet"}]]